The robust US IPO pipeline in 2026, with 238 deals completed through mid-September and additional listings scheduled for the fall window, forms the core driver of market-implied odds for at least one IPO before year-end 2026. Recent activity includes multiple September pricings such as Holtec Nuclear targeting an $825 million raise and smaller issuers like Orion180 Insurance, alongside ongoing SPAC activity and traditional filings. Equity market conditions remain supportive amid elevated valuations and investor appetite for growth sectors, though high-profile delays like OpenAI’s shift to 2027 highlight selectivity among mega-cap candidates. Key near-term catalysts include the September 18 expected debuts and any further S-1 filings that could accelerate before December, with resolution hinging on whether market volatility or regulatory timing disrupts the current cadence.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedMistral AI closes €3 billion funding round at €21 billion valuation
Mistral AI completed a €3 billion Series D funding round in September 2026, raising its valuation to approximately €21 billion (~$24 billion). The company confirmed IPO remains a long-term possibility but no immediate plans or filings have been made.
Mistral AI completes €3 billion Series D funding at €21 billion valuation
Mistral AI announced completion of a €3 billion Series D funding round on September 8, 2026, raising its valuation to over €21 billion. The company stated an IPO remains an option but has no scheduled date, focusing on growth and infrastructure expansion.
































Beware of external links.
Beware of external links.
Frequently Asked Questions